Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) OTC Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 OTC Drug Market Overview

    • 1.1 Product Overview and Scope of OTC Drug
    • 1.2 OTC Drug Segment by Type
      • 1.2.1 Global OTC Drug Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Class A
      • 1.2.3 Class B
    • 1.3 OTC Drug Segment by Application
      • 1.3.1 OTC Drug Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Hospital
      • 1.3.3 Clinic
      • 1.3.4 Household
    • 1.4 Global OTC Drug Market Size Estimates and Forecasts
      • 1.4.1 Global OTC Drug Revenue 2015-2026
      • 1.4.2 Global OTC Drug Sales 2015-2026
      • 1.4.3 OTC Drug Market Size by Region: 2020 Versus 2026

    2 Global OTC Drug Market Competition by Manufacturers

    • 2.1 Global OTC Drug Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global OTC Drug Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global OTC Drug Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers OTC Drug Manufacturing Sites, Area Served, Product Type
    • 2.5 OTC Drug Market Competitive Situation and Trends
      • 2.5.1 OTC Drug Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key OTC Drug Players (Opinion Leaders)

    3 OTC Drug Retrospective Market Scenario by Region

    • 3.1 Global OTC Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global OTC Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America OTC Drug Market Facts & Figures by Country
      • 3.3.1 North America OTC Drug Sales by Country
      • 3.3.2 North America OTC Drug Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe OTC Drug Market Facts & Figures by Country
      • 3.4.1 Europe OTC Drug Sales by Country
      • 3.4.2 Europe OTC Drug Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific OTC Drug Market Facts & Figures by Region
      • 3.5.1 Asia Pacific OTC Drug Sales by Region
      • 3.5.2 Asia Pacific OTC Drug Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America OTC Drug Market Facts & Figures by Country
      • 3.6.1 Latin America OTC Drug Sales by Country
      • 3.6.2 Latin America OTC Drug Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa OTC Drug Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa OTC Drug Sales by Country
      • 3.7.2 Middle East and Africa OTC Drug Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global OTC Drug Historic Market Analysis by Type

    • 4.1 Global OTC Drug Sales Market Share by Type (2015-2020)
    • 4.2 Global OTC Drug Revenue Market Share by Type (2015-2020)
    • 4.3 Global OTC Drug Price Market Share by Type (2015-2020)
    • 4.4 Global OTC Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global OTC Drug Historic Market Analysis by Application

    • 5.1 Global OTC Drug Sales Market Share by Application (2015-2020)
    • 5.2 Global OTC Drug Revenue Market Share by Application (2015-2020)
    • 5.3 Global OTC Drug Price by Application (2015-2020)

    6 Company Profiles and Key Figures in OTC Drug Business

    • 6.1 Bayer HealthCare
      • 6.1.1 Corporation Information
      • 6.1.2 Bayer HealthCare Description, Business Overview and Total Revenue
      • 6.1.3 Bayer HealthCare OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Bayer HealthCare Products Offered
      • 6.1.5 Bayer HealthCare Recent Development
    • 6.2 GlaxoSmithKline (GSK)
      • 6.2.1 GlaxoSmithKline (GSK) OTC Drug Production Sites and Area Served
      • 6.2.2 GlaxoSmithKline (GSK) Description, Business Overview and Total Revenue
      • 6.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 GlaxoSmithKline (GSK) Products Offered
      • 6.2.5 GlaxoSmithKline (GSK) Recent Development
    • 6.3 Johnson&Johnson
      • 6.3.1 Johnson&Johnson OTC Drug Production Sites and Area Served
      • 6.3.2 Johnson&Johnson Description, Business Overview and Total Revenue
      • 6.3.3 Johnson&Johnson OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Johnson&Johnson Products Offered
      • 6.3.5 Johnson&Johnson Recent Development
    • 6.4 Pfizer
      • 6.4.1 Pfizer OTC Drug Production Sites and Area Served
      • 6.4.2 Pfizer Description, Business Overview and Total Revenue
      • 6.4.3 Pfizer OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Pfizer Products Offered
      • 6.4.5 Pfizer Recent Development
    • 6.5 Sanofi
      • 6.5.1 Sanofi OTC Drug Production Sites and Area Served
      • 6.5.2 Sanofi Description, Business Overview and Total Revenue
      • 6.5.3 Sanofi OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Sanofi Products Offered
      • 6.5.5 Sanofi Recent Development
    • 6.6 AstraZeneca
      • 6.6.1 AstraZeneca OTC Drug Production Sites and Area Served
      • 6.6.2 AstraZeneca Description, Business Overview and Total Revenue
      • 6.6.3 AstraZeneca OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 AstraZeneca Products Offered
      • 6.6.5 AstraZeneca Recent Development
    • 6.7 BioGaia
      • 6.6.1 BioGaia OTC Drug Production Sites and Area Served
      • 6.6.2 BioGaia Description, Business Overview and Total Revenue
      • 6.6.3 BioGaia OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 BioGaia Products Offered
      • 6.7.5 BioGaia Recent Development
    • 6.8 Bristol Myers Squibb
      • 6.8.1 Bristol Myers Squibb OTC Drug Production Sites and Area Served
      • 6.8.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
      • 6.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Bristol Myers Squibb Products Offered
      • 6.8.5 Bristol Myers Squibb Recent Development
    • 6.9 Bukwang Pharmaceutica
      • 6.9.1 Bukwang Pharmaceutica OTC Drug Production Sites and Area Served
      • 6.9.2 Bukwang Pharmaceutica Description, Business Overview and Total Revenue
      • 6.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 Bukwang Pharmaceutica Products Offered
      • 6.9.5 Bukwang Pharmaceutica Recent Development
    • 6.10 Chr. Hansen
      • 6.10.1 Chr. Hansen OTC Drug Production Sites and Area Served
      • 6.10.2 Chr. Hansen Description, Business Overview and Total Revenue
      • 6.10.3 Chr. Hansen OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Chr. Hansen Products Offered
      • 6.10.5 Chr. Hansen Recent Development
    • 6.11 Cipla
      • 6.11.1 Cipla OTC Drug Production Sites and Area Served
      • 6.11.2 Cipla OTC Drug Description, Business Overview and Total Revenue
      • 6.11.3 Cipla OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Cipla Products Offered
      • 6.11.5 Cipla Recent Development
    • 6.12 CoLucid
      • 6.12.1 CoLucid OTC Drug Production Sites and Area Served
      • 6.12.2 CoLucid OTC Drug Description, Business Overview and Total Revenue
      • 6.12.3 CoLucid OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 CoLucid Products Offered
      • 6.12.5 CoLucid Recent Development
    • 6.13 Daiichi Sankyo
      • 6.13.1 Daiichi Sankyo OTC Drug Production Sites and Area Served
      • 6.13.2 Daiichi Sankyo OTC Drug Description, Business Overview and Total Revenue
      • 6.13.3 Daiichi Sankyo OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Daiichi Sankyo Products Offered
      • 6.13.5 Daiichi Sankyo Recent Development
    • 6.14 Friggs
      • 6.14.1 Friggs OTC Drug Production Sites and Area Served
      • 6.14.2 Friggs OTC Drug Description, Business Overview and Total Revenue
      • 6.14.3 Friggs OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 Friggs Products Offered
      • 6.14.5 Friggs Recent Development
    • 6.15 DSM
      • 6.15.1 DSM OTC Drug Production Sites and Area Served
      • 6.15.2 DSM OTC Drug Description, Business Overview and Total Revenue
      • 6.15.3 DSM OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 DSM Products Offered
      • 6.15.5 DSM Recent Development
    • 6.16 Eisai
      • 6.16.1 Eisai OTC Drug Production Sites and Area Served
      • 6.16.2 Eisai OTC Drug Description, Business Overview and Total Revenue
      • 6.16.3 Eisai OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.16.4 Eisai Products Offered
      • 6.16.5 Eisai Recent Development
    • 6.17 Eli Lilly
      • 6.17.1 Eli Lilly OTC Drug Production Sites and Area Served
      • 6.17.2 Eli Lilly OTC Drug Description, Business Overview and Total Revenue
      • 6.17.3 Eli Lilly OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.17.4 Eli Lilly Products Offered
      • 6.17.5 Eli Lilly Recent Development
    • 6.18 Herbalife
      • 6.18.1 Herbalife OTC Drug Production Sites and Area Served
      • 6.18.2 Herbalife OTC Drug Description, Business Overview and Total Revenue
      • 6.18.3 Herbalife OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.18.4 Herbalife Products Offered
      • 6.18.5 Herbalife Recent Development
    • 6.19 Euradite
      • 6.19.1 Euradite OTC Drug Production Sites and Area Served
      • 6.19.2 Euradite OTC Drug Description, Business Overview and Total Revenue
      • 6.19.3 Euradite OTC Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.19.4 Euradite Products Offered
      • 6.19.5 Euradite Recent Development

    7 OTC Drug Manufacturing Cost Analysis

    • 7.1 OTC Drug Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of OTC Drug
    • 7.4 OTC Drug Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 OTC Drug Distributors List
    • 8.3 OTC Drug Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global OTC Drug Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of OTC Drug by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of OTC Drug by Type (2021-2026)
    • 10.2 OTC Drug Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of OTC Drug by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of OTC Drug by Application (2021-2026)
    • 10.3 OTC Drug Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of OTC Drug by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of OTC Drug by Region (2021-2026)
    • 10.4 North America OTC Drug Estimates and Projections (2021-2026)
    • 10.5 Europe OTC Drug Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific OTC Drug Estimates and Projections (2021-2026)
    • 10.7 Latin America OTC Drug Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa OTC Drug Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global OTC Drug market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on OTC Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall OTC Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the OTC Drug market is segmented into
      Class A
      Class B

      Segment by Application
      Hospital
      Clinic
      Household

      Global OTC Drug Market: Regional Analysis
      The OTC Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the OTC Drug market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global OTC Drug Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global OTC Drug market include:
      Bayer HealthCare
      GlaxoSmithKline (GSK)
      Johnson&Johnson
      Pfizer
      Sanofi
      AstraZeneca
      BioGaia
      Bristol Myers Squibb
      Bukwang Pharmaceutica
      Chr. Hansen
      Cipla
      CoLucid
      Daiichi Sankyo
      Friggs
      DSM
      Eisai
      Eli Lilly
      Herbalife
      Euradite

      Buy now